RiverPark Advisors’s Medpace MEDP Stock Holding History

RiverPark Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-607	Closed	-$250K	–	138
2024 Q2	$250K	Buy	607 +53	+10%	+$21K	0.21%	75
2024 Q1	$224K	Buy	554 +468	+544%	+$165K	0.18%	76
2023 Q4	$26.4K	Buy	+86	New	+$23.2K	0.02%	91

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RiverPark Advisors's MEDP Position: Q3 2024 in Review

RiverPark Advisors sold out of Medpace (MEDP) in Q3 2024, closing a stake of 607 shares — an estimated $250K sold.

RiverPark Advisors first reported a position in MEDP in Q4 2023 and held it in 3 quarters. The position peaked at $250K in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

RiverPark Advisors reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
RiverPark Advisors sold 607 Medpace shares in Q3 2024, an estimated $250K.
RiverPark Advisors first reported a position in Medpace in Q4 2023 and held it in 3 quarters.
RiverPark Advisors's Medpace position peaked at $250K in Q2 2024.
583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on RiverPark Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.